Q3 2023 · 13F-HR
BRAIDWELL LPholdings as filed
Filed 2023-11-14 · accession 0001420506-23-002213
$3.16B
Reported value
86
Positions
2023-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 40131MAB5 | GH 0 11/15/27 | GUARDANT HEALTH INC | $185.8M | 5.87% | 268,252,000 | Common | SOLE |
| 67011XAB9 | NVCR 0 11/01/25 | NOVOCURE LTD | $118.0M | 3.73% | 135,834,000 | Common | SOLE |
| 04351PAD3 | ASND 2.25 04/01/28 | ASCENDIS PHARMA A/S | $113.8M | 3.60% | 124,000,000 | Common | SOLE |
| 30063PAC9 | EXAS 0.375 03/01/28 | EXACT SCIENCES CORP | $113.7M | 3.59% | 131,000,000 | Common | SOLE |
| 63009RAD1 | — | NANOSTRING TECHNOLOGIES INC | $112.4M | 3.55% | 145,520,000 | Common | SOLE |
| 10806XAB8 | BBIO 2.5 03/15/27 | BRIDGEBIO PHARMA INC | $109.8M | 3.47% | 114,338,000 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $108.9M | 3.44% | 968,024 | Common | SOLE |
| 64157FAC7 | — | NEVRO CORP | $102.0M | 3.22% | 109,251,000 | Common | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $82.6M | 2.61% | 1,619,553 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $71.9M | 2.27% | 2,103,396 | Common | SOLE |
| 101137107 | BSX | BOSTON SCIENTIFIC CORP | $61.5M | 1.94% | 1,164,850 | Common | SOLE |
| 52490G102 | LEGN | LEGEND BIOTECH CORP | $59.1M | 1.87% | 879,564 | Common | SOLE |
| 670704AJ4 | GMED 0.375 03/15/25 | NUVASIVE INC | $56.6M | 1.79% | 61,340,000 | Common | SOLE |
| 45784PAK7 | PODD 0.375 09/01/26 | INSULET CORP | $53.6M | 1.69% | 54,500,000 | Common | SOLE |
| 450056106 | IRTC | IRHYTHM TECHNOLOGIES INC | $53.6M | 1.69% | 568,157 | Common | SOLE |
| 377322102 | GKOS | GLAUKOS CORP | $52.4M | 1.65% | 695,792 | Common | SOLE |
| 462222AD2 | IONS 0 04/01/26 | IONIS PHARMACEUTICALS INC | $51.8M | 1.64% | 52,740,000 | Common | SOLE |
| 10806XAD4 | BBIO 2.25 02/01/29 | BRIDGEBIO PHARMA INC | $50.5M | 1.59% | 67,294,000 | Common | SOLE |
| 803607AD2 | SRPT 1.25 09/15/27 | SAREPTA THERAPEUTICS INC | $49.5M | 1.57% | 44,166,000 | Common | SOLE |
| 761299AB2 | TVTX 2.5 09/15/25 | TRAVERE THERAPEUTICS INC | $48.2M | 1.52% | 56,031,000 | Common | SOLE |
| 45258D105 | IMCR | IMMUNOCORE HLDGS PLC | $47.1M | 1.49% | 906,973 | Common | SOLE |
| 23954D109 | DAWNGBX | DAY ONE BIOPHARMACEUTICALS I | $45.6M | 1.44% | 3,715,573 | Common | SOLE |
| 64049MAB6 | NEO 0.25 01/15/28 | NEOGENOMICS INC | $45.2M | 1.43% | 62,601,000 | Common | SOLE |
| 632307104 | NTRA | NATERA INC | $44.8M | 1.42% | 1,012,145 | Common | SOLE |
| 492327101 | KROS | KEROS THERAPEUTICS INC | $43.3M | 1.37% | 1,357,309 | Common | SOLE |
| 02081GAB8 | ATEC 0.75 08/01/26 | ALPHATEC HLDGS INC | $43.1M | 1.36% | 44,750,000 | Common | SOLE |
| 24344T101 | DCPHEUR | DECIPHERA PHARMACEUTICALS IN | $42.4M | 1.34% | 3,336,221 | Common | SOLE |
| 69913P105 | FNAUSD | PARAGON 28 INC | $42.2M | 1.33% | 3,361,824 | Common | SOLE |
| 48576UAA4 | — | KARYOPHARM THERAPEUTICS INC | $40.9M | 1.29% | 65,976,000 | Common | SOLE |
| 56600D107 | MRVI | MARAVAI LIFESCIENCES HLDGS I | $39.7M | 1.26% | 3,974,857 | Common | SOLE |
| 457669AA7 | — | INSMED INC | $39.7M | 1.26% | 39,963,000 | Common | SOLE |
| 883556102 | TMO | THERMO FISHER SCIENTIFIC INC | $38.3M | 1.21% | 75,749 | Common | SOLE |
| 016255101 | ALGN | ALIGN TECHNOLOGY INC | $38.2M | 1.21% | 125,213 | Common | SOLE |
| 09058V103 | BCRX | BIOCRYST PHARMACEUTICALS INC | $38.0M | 1.20% | 5,362,980 | Common | SOLE |
| 46333XAF5 | — | IRONWOOD PHARMACEUTICALS INC | $37.3M | 1.18% | 37,509,000 | Common | SOLE |
| 252131AK3 | DXCM 0.25 11/15/25 | DEXCOM INC | $35.5M | 1.12% | 37,500,000 | Common | SOLE |
| 64157F103 | NVROEUR | NEVRO CORP | $34.1M | 1.08% | 1,776,368 | Common | SOLE |
| 68752L100 | KIDS | ORTHOPEDIATRICS CORP | $33.8M | 1.07% | 1,057,770 | Common | SOLE |
| 46120E602 | ISRG | INTUITIVE SURGICAL INC | $33.6M | 1.06% | 114,920 | Common | SOLE |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $26.6M | 0.84% | 1,735,182 | Common | SOLE |
| 014442107 | ALEC | ALECTOR INC | $26.4M | 0.83% | 4,074,120 | Common | SOLE |
| 64049MAA8 | — | NEOGENOMICS INC | $26.3M | 0.83% | 28,000,000 | Common | SOLE |
| 690145107 | OMGBP | OUTSET MED INC | $26.1M | 0.83% | 2,400,427 | Common | SOLE |
| 415858109 | HROW | HARROW INC | $26.0M | 0.82% | 1,808,684 | Common | SOLE |
| 088786108 | BCYC | BICYCLE THERAPEUTICS PLC | $25.9M | 0.82% | 1,289,872 | Common | SOLE |
| 282559103 | ETNBGBP | 89BIO INC | $24.6M | 0.78% | 1,590,387 | Common | SOLE |
| 70975L107 | PEN | PENUMBRA INC | $23.1M | 0.73% | 95,315 | Common | SOLE |
| 40131M109 | GH | GUARDANT HEALTH INC | $20.4M | 0.65% | 689,000 | Common | SOLE |
| 516544103 | LNTH | LANTHEUS HLDGS INC | $20.0M | 0.63% | 288,300 | Common | SOLE |
| 232109AD0 | — | CUTERA INC | $20.0M | 0.63% | 33,900,000 | Common | SOLE |
| 457730109 | INSP | INSPIRE MED SYS INC | $19.9M | 0.63% | 100,300 | Common | SOLE |
| 05465P101 | AXNX* | AXONICS INC | $19.9M | 0.63% | 354,527 | Common | SOLE |
| 43157M102 | — | HILLEVAX INC | $19.5M | 0.62% | 1,449,246 | Common | SOLE |
| 603170101 | MLYS | MINERALYS THERAPEUTICS INC | $19.2M | 0.61% | 2,023,900 | Common | SOLE |
| 235851102 | DHR | DANAHER CORPORATION | $19.2M | 0.61% | 77,200 | Common | SOLE |
| 032724106 | ANAB | ANAPTYSBIO INC | $18.9M | 0.60% | 1,049,823 | Common | SOLE |
| 759916109 | RGEN | REPLIGEN CORP | $18.8M | 0.59% | 118,400 | Common | SOLE |
| 74366E102 | PTGX | PROTAGONIST THERAPEUTICS INC | $18.5M | 0.58% | 1,109,150 | Common | SOLE |
| 89422GAA5 | TVTX 2.25 03/01/29 | TRAVERE THERAPEUTICS INC | $18.4M | 0.58% | 28,350,000 | Common | SOLE |
| 75382E109 | — | RAPT THERAPEUTICS INC | $18.0M | 0.57% | 1,082,512 | Common | SOLE |
| 230031106 | CGEM | CULLINAN ONCOLOGY INC | $17.3M | 0.55% | 1,908,865 | Common | SOLE |
| 45337C102 | INCY | INCYTE CORP | $17.0M | 0.54% | 294,900 | Common | SOLE |
| 89377M109 | TMDX | TRANSMEDICS GROUP INC | $16.8M | 0.53% | 307,200 | Common | SOLE |
| 23306J101 | — | DBV TECHNOLOGIES S A | $16.5M | 0.52% | 12,107,785 | Common | SOLE |
| 26818M108 | DYN | DYNE THERAPEUTICS INC | $16.3M | 0.52% | 1,821,972 | Common | SOLE |
| 46333XAH1 | IRWD 1.5 06/15/26 | IRONWOOD PHARMACEUTICALS INC | $15.1M | 0.48% | 15,500,000 | Common | SOLE |
| 46185LAB9 | — | INVITAE CORP | $14.9M | 0.47% | 16,781,000 | Common | SOLE |
| 880881107 | 430 | TERNS PHARMACEUTICALS INC | $14.3M | 0.45% | 2,840,052 | Common | SOLE |
| 457985AM1 | IART 0.5 08/15/25 | INTEGRA LIFESCIENCES HLDGS C | $13.3M | 0.42% | 14,500,000 | Common | SOLE |
| 46333X108 | IRWD | IRONWOOD PHARMACEUTICALS INC | $13.0M | 0.41% | 1,348,099 | Common | SOLE |
| 20454B104 | CMPX | COMPASS THERAPEUTICS INC | $11.7M | 0.37% | 5,954,273 | Common | SOLE |
| 29251M106 | ENTA | ENANTA PHARMACEUTICALS INC | $11.6M | 0.37% | 1,038,310 | Common | SOLE |
| 74276L105 | PRCT | PROCEPT BIOROBOTICS CORP | $10.9M | 0.34% | 331,061 | Common | SOLE |
| 88427A107 | — | THIRD HARMONIC BIO INC | $10.6M | 0.33% | 1,653,991 | Common | SOLE |
| 03770N101 | APGE | APOGEE THERAPEUTICS INC | $10.5M | 0.33% | 491,113 | Common | SOLE |
| 745848101 | LUNG | PULMONX CORP | $10.2M | 0.32% | 988,559 | Common | SOLE |
| 88331L108 | SKIN | THE BEAUTY HEALTH COMPANY | $9.8M | 0.31% | 1,626,236 | Common | SOLE |
| 031162100 | AMGN | AMGEN INC | $9.7M | 0.31% | 36,200 | Common | SOLE |
| 81181C104 | — | SEAGEN INC | $9.0M | 0.28% | 42,497 | Common | SOLE |
| 501147102 | KRYS | KRYSTAL BIOTECH INC | $9.0M | 0.28% | 77,497 | Common | SOLE |
| 76029N106 | REPL | REPLIMUNE GROUP INC | $8.3M | 0.26% | 487,520 | Common | SOLE |
| 00847G705 | AGENEUR | AGENUS INC | $7.1M | 0.23% | 6,307,030 | Common | SOLE |
| 75525N107 | — | RAYZEBIO INC | $6.2M | 0.19% | 277,778 | Common | SOLE |
| 00166B105 | ALXO | ALX ONCOLOGY HLDGS INC | $6.0M | 0.19% | 1,249,900 | Common | SOLE |
| 00650F109 | ADPT | ADAPTIVE BIOTECHNOLOGIES COR | $5.3M | 0.17% | 967,690 | Common | SOLE |
| N5749R100 | 2GH | MERUS N V | $0 | — | 1,901,337 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.